Predictors of retention in the treatment for opioid dependence: A prospective, observational study from India

Background: Literature on a longitudinal study of the determinants of treatment retention for patients with opioid dependence is limited. Aim: To find out patient- and treatment-related (buprenorphine-naloxone-assisted treatment [BNX treatment] versus naltrexone treatment) predictors for retention i...

Full description

Bibliographic Details
Published in:	Indian Journal of Psychiatry
Main Authors:	Anish Shouan, Abhishek Ghosh, Shubh Mohan Singh, Debasish Basu, Surendra Kumar Mattoo
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2021-07-01
Subjects:	buprenorphine-naloxone dropout naltrexone opioid dependence treatment
Online Access:	https://journals.lww.com/10.4103/psychiatry.IndianJPsychiatry_448_20

Similar Items

The Potential of Methocinnamox as a Future Treatment for Opioid Use Disorder: A Narrative Review
by: Colleen G. Jordan, et al.
Published: (2022-04-01)

Jail-based interventions to reduce risk for opioid-related overdose deaths: Examples of implementation within Ohio counties participating in the HEALing Communities Study
by: Joel Sprunger, et al.
Published: (2024-12-01)

Long-term agonist and antagonist therapy for adolescent opioid dependence: A description of two cases
by: Rajeev Ranjan, et al.
Published: (2014-01-01)

Multimodal Acute Pain Management in the Parturient with Opioid Use Disorder: A Review
by: Koltenyuk V, et al.
Published: (2024-02-01)

Co-relationship between sexual dysfunction and high-risk sexual behavior in patients receiving buprenorphine and naltrexone maintenance therapy for opioid dependence
by: Santosh Ramdurg, et al.
Published: (2015-01-01)

Prior National Drug Abuse Treatment Clinical Trials Network (CTN) opioid use disorder trials as background and rationale for NIDA CTN-0100 “optimizing retention, duration and discontinuation strategies for opioid use disorder pharmacotherapy (RDD)”
by: Matisyahu Shulman, et al.
Published: (2021-03-01)

Six-month buprenorphine-naloxone treatment is associated with neurocognitive function improvement in opioid dependence
by: Abhishek Ghosh, et al.
Published: (2022-03-01)

Treatment of dissociative symptoms with opioid antagonists: a systematic review
by: Irene Escamilla, et al.
Published: (2023-11-01)

Mc Donalds’ model of deliverance of opioid substitution treatment in COVID-19 crisis in opioid belt in rural India : A retrospective - comparative study
by: G. Uppal
Published: (2021-04-01)

Comparison of Buprenorphine and Buprenorphine/naloxone in Detoxification of Opioid-dependent Men
by: Hassan Ziaaddini, et al.
Published: (2018-12-01)

THE COVID-19 PANDEMIC AND THE OPIOID CRISIS IN UNITED STATES OF AMERICA
by: Muhammad Aadil, et al.
Published: (2021-03-01)

Editorial: Reviews in opioid use disorders
by: Wendy Walwyn, et al.
Published: (2024-08-01)

Large variations in all-cause and overdose mortality among >13,000 patients in and out of opioid maintenance treatment in different settings: a comparative registry linkage study
by: Roman Gabrhelík, et al.
Published: (2023-09-01)

Buprenorphine‐naloxone, buprenorphine, and methadone throughout pregnancy in maternal opioid use disorder
by: Minna M. Kanervo, et al.
Published: (2023-03-01)

Primary care management of Long-Term opioid therapy
by: Phillip O. Coffin, et al.
Published: (2022-12-01)

Impact of an opioid use disorder medication implementation intervention on hospitalization and emergency department utilization in the Veterans Health Administration
by: Madeline C. Frost, et al.
Published: (2025-03-01)

Hailey-Hailey disease successfully treated with naloxone: 2 case reports and Review of the literature on efficacy of opioid receptor antagonist in Hailey-Hailey disease patients
by: Junyou Zheng, et al.
Published: (2025-12-01)

Antidotes for opioid overdose: a search for variations for their modification (literature review)
by: O. A. Dravolina, et al.
Published: (2024-12-01)

Non-prescribed use of methadone and buprenorphine prior to opioid substitution treatment: lifetime prevalence, motives, and drug sources among people with opioid dependence in five Swedish cities
by: Björn Johnson, et al.
Published: (2019-05-01)

The association of medical providers’ attitudes about naloxone and treating people with opioid use disorder and their self-reported low-barrier treatment practices
by: Rachel P. Winograd, et al.
Published: (2023-12-01)

Breaking barriers: Assessing the feasibility and acceptability of telemedicine-assisted buprenorphine induction for opioid use disorder in India
by: Abhishek Ghosh, et al.
Published: (2024-10-01)

Naloxone and Metabolites Quantification in Cord Blood of Prenatally Exposed Newborns and Correlations with Maternal Concentrations
by: Samantha L. Wiegand, et al.
Published: (2016-10-01)

Patient-reported problems filling buprenorphine prescriptions and motivations for illicit use
by: Erin L. Winstanley, et al.
Published: (2022-12-01)

Utilizing resources of neuropsychopharmacology to address the opioid overdose crisis
by: Anthony G. Phillips, et al.
Published: (2018-09-01)

Policies, adaptations, and ongoing challenges to naloxone, buprenorphine and nonprescription syringe access across four-states: Findings from an environmental scan and key informant interviews
by: Anthony S. Floyd, et al.
Published: (2024-06-01)

Transition From Full Mu Opioid Agonists to Buprenorphine in Opioid Dependent Patients—A Critical Review
by: Michael Soyka
Published: (2021-11-01)

Buprenorphine/naloxone versus methadone opioid rotation in patients with prescription opioid use disorder and chronic pain: study protocol for a randomized controlled trial
by: Hannah Ellerbroek, et al.
Published: (2022-09-01)

Management of buprenorphine/naloxone therapy in substances abuse consumers in prison: efficacy and safety
by: Felice A. Nava
Published: (2018-11-01)

Perioperative Pain Management for Median Sternotomy in a Patient on Chronic Buprenorphine/Naloxone Maintenance Therapy: Avoiding Opioids in Patients at Risk for Relapse
by: Alalade E, et al.
Published: (2020-02-01)

Drug use patterns and factors related to the use and discontinuation of medications for opioid use disorder in the age of fentanyl: findings from a mixed-methods study of people who use drugs
by: Jaclyn M. W. Hughto, et al.
Published: (2023-05-01)

Single high-dose buprenorphine for opioid craving during withdrawal
by: Jamshid Ahmadi, et al.
Published: (2018-12-01)

Buprenorphine therapy in the setting of induced opioid withdrawal from oral naltrexone: a case report
by: Laura M. Szczesniak, et al.
Published: (2020-10-01)

Predictors of Sexual Dysfunction in Women Seeking Treatment for Opioid Use Disorder: A Comparative Cross-Sectional Study from a Tertiary Center
by: Nazife Gamze Usta Saglam, et al.
Published: (2023-11-01)

Prior authorization restrictions on medications for opioid use disorder: trends in state laws from 2005 to 2019
by: Barbara Andraka-Christou, et al.
Published: (2023-12-01)

Buprenorphine/naloxone – one formulation that doesn’t fit all: a case report
by: Hannan M. Braun, et al.
Published: (2024-07-01)

Safety and Efficacy of Buprenorphine-Naloxone in Pregnancy: A Systematic Review of the Literature
by: Alice Ordean, et al.
Published: (2023-02-01)

Receipt of medications for opioid use disorders among veterans by race/ethnicity and legal involvement: an observational study of electronic health records
by: Andrea K. Finlay, et al.
Published: (2025-04-01)

Patient-elected low-dose intravenous naloxone for rapid buprenorphine induction: a case report
by: Pouya Azar, et al.
Published: (2025-05-01)

Sleep problems in opioid dependent patients maintained on buprenorphine
by: R. Tripathi, et al.
Published: (2021-04-01)

Development and implementation of a physician-pharmacist collaborative practice model for provision and management of buprenorphine/naloxone
by: Lindsay M. Mailloux, PharmD, et al.
Published: (2021-01-01)